durapatite has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermann, P; Kolar, ZI; Kotek, J; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Rudovský, J; Vander Elst, L; Wolterbeek, HT | 1 |
| Hermann, P; Kolar, ZI; Kubícek, V; Lukes, I; Peters, JA; Vitha, T; Wolterbeek, HT | 1 |
| Hermann, P; Kotek, J; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Vander Elst, L; Vitha, T | 1 |
| Kanbara, H; Kitamura, Y; Kiwada, T; Odani, A; Ogawa, K; Shiba, K; Takai, K | 1 |
| Ishizaki, A; Kitamura, Y; Kiwada, T; Odani, A; Ogawa, K; Shiba, K; Takai, K | 1 |
| Hermann, P; Kubíček, V; Meckel, M; Miederer, M; Rösch, F | 1 |
| Chakraborty, S; Chakravarty, R; Dash, A; Goswami, D; Mohammed, SK; Sarma, HD | 1 |
7 other study(ies) available for durapatite and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting.
Topics: Adsorption; Amides; Binding, Competitive; Biocompatible Materials; Bone and Bones; Chelating Agents; Diphosphonates; Durapatite; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Structure | 2005 |
Complexes of DOTA-bisphosphonate conjugates: probes for determination of adsorption capacity and affinity constants of hydroxyapatite.
Topics: Adsorption; Binding, Competitive; Diphosphonates; Durapatite; Heterocyclic Compounds, 1-Ring; Macromolecular Substances; Molecular Structure | 2008 |
Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues.
Topics: Bone and Bones; Calcinosis; Chelating Agents; Contrast Media; Crystallography, X-Ray; Diagnostic Imaging; Durapatite; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Molecular Structure; Organophosphonates; Radiography | 2009 |
Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent.
Topics: Animals; Bone and Bones; Bone Neoplasms; Chelating Agents; Diphosphonates; Drug Stability; Durapatite; Gallium Radioisotopes; Half-Life; Heterocyclic Compounds, 1-Ring; Male; Mice; Organometallic Compounds; Positron-Emission Tomography | 2011 |
Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers.
Topics: Bone and Bones; Chromatography, High Pressure Liquid; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Molecular Structure; Peptides; Positron-Emission Tomography; Solid-Phase Synthesis Techniques | 2013 |
A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.
Topics: Adsorption; Animals; Bone and Bones; Diphosphonates; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Positron-Emission Tomography; Rats; Rats, Wistar; Serum Albumin; Tissue Distribution | 2016 |
Syntheses and evaluation of
Topics: Adsorption; Animals; Coordination Complexes; Diphosphonates; Drug Stability; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Ligands; Male; Muscle, Skeletal; Pain; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Samarium; Tissue Distribution | 2018 |